Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834677 · ClinicalTrials.gov registry record
Translational Research Evaluating Neurocognitive Memory Processes
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 76
- Enrollment target
NCT01834677 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 76 participants.
The verdict
NCT01834677 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the psychometric properties and utility of new, computerized, neurocognitive measures in humans with depression, and humans with depression undergoing electroconvulsive therapy (ECT). The benefits of the study outweigh the risk as there is the possibility of developing better computerized neurocognitive measures, and the risks are limited to no more than minimal test related fatigue and psychological stress. Depressed humans, depressed human participants undergoing ECT, and humans diagnosed with Parkinson's disease (age 18-85) will be invited to participate in this study. After providing informed consent participants will undergo a clinical psychiatric evaluation to confirm the inclusion/exclusion criteria. After the clinical psychiatric evaluation, participants will complete common and new neurocognitive measures. There will be a total of two testing visits (baseline, 1-month follow-up). The anticipated duration of the participant's involvement is no more than 2 study visits that can take place over a 4-day period (i.e., the clinical evaluation can occur on day 1 and the neuropsychological measures can be administered on day 2 of each study visit) equating to approximately 6-hours (3-hours each day) per study visit.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01834677
The ClinicalTrials.gov registry entry for NCT01834677 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01834677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01834677 about?
NCT01834677 is a clinical study titled "Translational Research Evaluating Neurocognitive Memory Processes". The purpose of this study is to evaluate the psychometric properties and utility of new, computerized, neurocognitive measures in humans with depression, and humans with depression undergoing electroconvulsive therapy (ECT). The benefits of the study outweigh the risk as there is the possibility of ...
What is the current status of trial NCT01834677?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2013-04. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT01834677?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.